(Name of Issuer) |
(Title of Class of Securities) |
(CUSIP Number) |
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
|
(Date of Event which Requires Filing of this Statement) |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
Covington Health Group, LLC | ||
45-2041708 |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | WC |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization ............................................................................................................................. | DE |
7. | Sole Voting Power | -0- | ||
Number of | ||||
Shares | 327,044 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | -0- | |
Person | ||||
With | 10. | Shared Dispositive Power | 327,044 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 327,044 |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 5.6%** |
14. | Type of Reporting Person (See Instructions) | OO |
CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
John E. McMullan |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(c) | ............................................................................................................................................................................................ | ü | |
(d) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | PF |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization.............................................................................................................................. | United States |
7. | Sole Voting Power | 215,060 | ||
Number of | ||||
Shares | 327,044 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | 215,060 | |
Person | ||||
With | 10. | Shared Dispositive Power | 327,044 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 542,104* |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 9.3%** |
14. | Type of Reporting Person (See Instructions) | IN |
CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
John F. McMullan |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | PF |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization.............................................................................................................................. | United States |
7. | Sole Voting Power | 123,000 | ||
Number of | ||||
Shares | 327,044 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | 123,000 | |
Person | ||||
With | 10. | Shared Dispositive Power | 327,044 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 450,044* |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 7.7%** |
14. | Type of Reporting Person (See Instructions) | IN |
CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
Camden Real Estate Company | ||
58-1913586 |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | WC |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization ............................................................................................................................. | GA |
7. | Sole Voting Power | 30,000 | ||
Number of | ||||
Shares | 327,044 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | 30,000 | |
Person | ||||
With | 10. | Shared Dispositive Power | 327,044 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 357,044* |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 6.1%** |
14. | Type of Reporting Person (See Instructions) | CO |
CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
Joseph T. Watters, III |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | PF |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization ............................................................................................................................. | United States |
7. | Sole Voting Power | 163,900 | ||
Number of | ||||
Shares | 327,044 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | 163,900 | |
Person | ||||
With | 10. | Shared Dispositive Power | 327,044 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 490,944* |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 8.4%** |
14. | Type of Reporting Person (See Instructions) | IN |
Item 1. | Security and Issuer |
Item 2. | Identity and Background |
a) |
This Schedule 13D/A is being filed on behalf of the following persons (collectively, the “Reporting Persons”):
|
(i) | Covington Health Group, LLC | |
(ii) | John E. McMullan | |
(iii) | John F. McMullan | |
(iv) |
Camden Real Estate Company
|
|
(v) |
Joseph T. Watters, III
|
|
Attached as Exhibit A is a copy of the agreement among the foregoing persons that the Schedule 13D initially filed to report the acquisition that is the subject of this Schedule 13D/A be filed on behalf of each of them.
|
b) |
The address of the principal business offices of each of the Reporting Persons, with the exception of Joseph T. Watters, III, is 1175 Peachtree Street, Suite 350, Atlanta, GA 30361. The address of the principal business offices of Joseph T. Watters, III is P.O. Box 470, Adairsville, GA 30103.
|
|
c) |
Covington Health Group, LLC is a Delaware limited liability company engaged in the business of investments. Camden Real Estate Company is a Georgia investment company. The principal occupation of John E. McMullan and John F. McMullan is the operation of senior living communities, and the principal occupation of Joseph T. Watters, III, is wholesale manufacturing.
|
|
d) |
None.
|
|
e) |
None.
|
|
f) |
Citizenship:
|
(i) | Covington Health Group, LLC, a Delaware limited liability company | |
(ii) | John E. McMullan: United States | |
(iii) | John F. McMullan: United States | |
(iv) |
Camden Real Estate Company, a Georgia corporation
|
|
(v) |
Joseph T. Watters, III: United States
|
Item 3. | Source and Amount of Funds or Other Consideration |
Item 4. | Purpose of Transaction |
Item 5. | Interest in Securities of the Issuer |
(a) | See pages 2 – 6 of cover pages. The Reporting Persons together as a group own 859,004 shares of the Issuer’s common stock, which constitutes 14.7% of the Issuer’s common stock. | |
(b) | See pages 2 - 6 of cover pages. | |
(c) | Transactions in the Issuer’s securities in the last 60 days: |
Reporting Person: Covington Health Group, LLC | |
|
- On January 12, 2012, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
• | 1743 shares at $5.76 per share | |
• | 500 shares at $5.76 per share | |
• | 1700 shares at $5.76 per share |
|
•
|
500 shares at $5.76 per share
|
|
•
|
57 shares at $5.76 per share
|
|
•
|
43 shares at $576 per share
|
|
•
|
100 shares at $5.76 per share
|
|
•
|
357 shares at $5.76 per share
|
|
- On December 1, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
|
•
|
500 shares at $5.95 per share
|
|
•
|
804 shares at $5.95 per share
|
|
•
|
500 shares at $5.95 per share
|
|
•
|
4500 shares at $5.95 per share
|
|
•
|
500 shares at $5.95 per share
|
|
•
|
100 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
100 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
500 shares at $5.95 per share
|
|
•
|
800 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
100 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
500 shares at $5.95 per share
|
|
•
|
100 shares at $5.95 per share
|
|
•
|
100 shares at $5.95 per share
|
|
•
|
400 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
300 shares at $5.95 per share
|
|
•
|
500 shares at $5.95 per share
|
|
•
|
200 shares at $5.95 per share
|
|
- On November 29, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
|
•
|
100 shares at $5.950 per share
|
|
•
|
100 shares at $5.950 per share
|
|
•
|
100 shares at $5.950 per share
|
|
•
|
100 shares at $5.950 per share
|
|
•
|
100 shares at $5.950 per share
|
|
•
|
100 shares at $5.950 per share
|
|
•
|
100 shares at $5.950 per share
|
|
•
|
200 shares at $5.950 per share
|
|
•
|
200 shares at $5.950 per share
|
|
•
|
100 shares at $5.950 per share
|
|
•
|
500 shares at $5.885 per share
|
|
•
|
100 shares at $5.885 per share
|
|
•
|
300 shares at $5.885 per share
|
|
•
|
300 shares at $5.890 per share
|
|
•
|
96 shares at $5.880 per share
|
|
•
|
200 shares at $5.880 per share
|
|
•
|
5000 shares at $5.890 per share
|
-On November 16, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions: |
|
•
|
100 shares at $5.775 per share
|
|
•
|
40 shares at $5.75 per share
|
|
•
|
100 shares at $5.76 per share
|
|
•
|
3500 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
500 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
2771 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
500 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
7900 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
400 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
6300 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
300 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
400 shares at $5.80 per share
|
|
•
|
9100 shares at $5.80 per share
|
|
•
|
300 shares at $5.80 per share
|
|
•
|
2100 shares at $5.80 per share
|
|
•
|
4700 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
8400 shares at $5.80 per share
|
|
•
|
300 shares at $5.80 per share
|
|
•
|
7700 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
30 shares at $5.79 per share
|
|
•
|
100 shares at $5.79 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
200 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
100 shares at $5.80 per share
|
|
•
|
200 shares at $5.79 per share
|
|
•
|
300 shares at $5.79 per share
|
|
•
|
200 shares at $5.78 per share
|
|
•
|
300 shares at $5.80 per share
|
-On November 7, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions: |
|
•
|
100 shares at $5.75 per share
|
|
•
|
188 shares at $5.75 per share
|
|
•
|
83 shares at $5.725 per share
|
|
•
|
300 shares at $5.75 per share
|
|
•
|
200 shares at $5.75 per share
|
|
•
|
1000 shares at $5.75 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
200 shares at $5.75 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
200 shares at $5.95 per share
|
|
•
|
100 shares at $5.95 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
17 shares at $5.75 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
100 shares at $5.75 per share
|
|
•
|
800 shares at $5.75 per share
|
|
•
|
300 shares at $5.75 per share
|
|
•
|
200 shares at $5.73 per share
|
|
•
|
300 shares at $5.73 per share
|
|
•
|
200 shares at $5.75 per share
|
|
•
|
100 shares at $5.73 per share
|
|
•
|
100 shares at $5.72 per share
|
|
•
|
100 shares at $5.73 per share
|
|
•
|
200 shares at $5.72 per share
|
-On November 4, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions: |
|
•
|
100 shares at $5.77 per share
|
|
•
|
700 shares at $5.77 per share
|
|
•
|
3 shares at $5.75 per share
|
|
•
|
500 shares at $5.75 per share
|
-On November 3, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions: |
•
|
900 shares at $5.75 per share
|
|
•
|
753 shares at $5.75 per share
|
|
•
|
2500 shares at $5.8799 per share
|
|
•
|
11 shares at $5.85 per share
|
|
•
|
900 shares at $5.85 per share
|
|
•
|
100 shares at $5.84 per share
|
|
•
|
100 shares at $5.84 per share
|
|
•
|
100 shares at $5.65 per share
|
-On October 5, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions: |
•
|
200 shares at $5.65 per share
|
|
•
|
200 shares at $5.65 per share
|
|
•
|
400 shares at $5.65 per share
|
|
•
|
100 shares at $5.48 per share
|
|
•
|
300 shares at $5.47 per share
|
|
•
|
551 shares at $5.65 per share
|
-On October 4, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions: |
•
|
100 shares at $5.7499 per share
|
•
|
400 shares at $5.7499 per share
|
|
•
|
1 share at $5.50 per share
|
-On October 3, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions: |
•
|
5000 shares at $5.75 per share
|
|
(d)
|
N/A
|
Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect to the Securities of the Issuer |
Item 7. | Materials to be Filed as Exhibits |
Exhibit A. | Joint Filing Agreement |
Exhibit B. | Power of Attorney |
Exhibit C. | Power of Attorney |
Exhibit D. | Power of Attorney |
COVINGTON HEALTH GROUP, LLC |
By: | /s/ John E. McMullan* |
Name: John E. McMullan | |
Title: Manager |
|
CAMDEN REAL ESTATE COMPANY |
By: | /s/ John F. McMullan** |
Name: John F. McMullan | |
Title: Presiden |
/s/ John E. McMullan* | ||
John E. McMullan |
/s/ John F. McMullan** | ||
John F. McMullan |
/s/ Joseph T. Watters, III*** | ||
Joseph T. Watters, III |
* | By Attorney-in-Fact, pursuant to Power of Attorney attached to this Schedule 13D/A as Exhibit B. |
** | By Attorney-in-Fact, pursuant to Power of Attorney attached to this Schedule 13D/A as Exhibit C. |
*** | By Attorney-in-Fact, pursuant to Power of Attorney attached to this Schedule 13D/A as Exhibit D. |
COVINGTON HEALTH GROUP, LLC |
By: | /s/ John E. McMullan |
Name: John E. McMullan | |
Title: Manager |
|
CAMDEN REAL ESTATE COMPANY |
By: | /s/ John F. McMullan |
Name: John F. McMullan | |
Title: Presiden |
/s/ John E. McMullan | ||
John E. McMullan |
/s/ John F. McMullan | ||
John F. McMullan |
/s/ Joseph T. Watters, III | ||
Joseph T. Watters, III |
1.
|
execute for and on behalf of the undersigned, in the undersigned's individual capacity and in the undersigned’s capacity as manager of Covington Health Group, LLC (the “Company”), a Schedule 13D and any and all amendments thereto, and a Joint Filing Agreement in connection therewith, with respect to the undersigned’s and the Company's holdings of and transactions in securities issued by Advocat, Inc., in accordance with Section 13(d) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder;
|
2.
|
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D, complete and execute any amendment or amendments thereto, execute a Joint Filing Agreement in connection therewith, and timely file such schedule and agreement with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
|
3.
|
take any and all other actions of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
|
1.
|
execute for and on behalf of the undersigned, in the undersigned’s individual capacity and in the undersigned's capacity as President of Camden Real Estate Company (the “Company”), a Schedule 13D and any and all amendments thereto, and a Joint Filing Agreement in connection therewith, with respect to the undersigned’s and the Company's holdings of and transactions in securities issued by Advocat, Inc., in accordance with Section 13(d) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder;
|
2.
|
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D, complete and execute any amendment or amendments thereto, execute a Joint Filing Agreement in connection therewith, and timely file such schedule and agreement with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
|
3.
|
take any and all other actions of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
|
1.
|
execute for and on behalf of the undersigned a Schedule 13D and any and all amendments thereto, and a Joint Filing Agreement in connection therewith, with respect to the undersigned’s holdings of and transactions in securities issued by Advocat, Inc., in accordance with Section 13(d) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder;
|
2.
|
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D, complete and execute any amendment or amendments thereto, execute a Joint Filing Agreement in connection therewith, and timely file such schedule and agreement with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
|
3.
|
take any and all other actions of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
|